Resources
Reaching European attendees, our 2023 Post-ESMO report sought to understand the event’s areas of greatest interest. 95 European oncologists and haematologist-oncologists shared with us the findings and developments they found most exciting.
Learn what respondents thought of the latest advancements including NSCLC, breast cancer, and Urothelial cancer treatments.
Download the report today.
Discover the Impact of Hurricane Helene on IV Fluid Availability When Hurricane Helene disrupted a key IV fluid manufacturing facility in the southeastern US, healthcare systems felt the ripple effects. InCrowd conducted research to uncover how this shortage has...
Physician Engagement in a Time of Accelerated Professional Burnout As burnout remains a significant challenge for healthcare professionals (HCPs), emerging research indicates a potential shift in this landscape. Our newest report unveils insights from a recent...
Reactions and Insights from Hematologists and Hematology-Oncologists at ASH 2023 In December 2023, the American Society of Hematology (ASH) held its Annual Meeting, and InCrowd conducted a 1-minute MicroSurvey to gather insights from 100 US-based Hematologists and...